Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,900.00
+21.20 (1.13%)
Jul 31, 2026, 3:29 PM IST
Dr. Lal PathLabs Revenue
Dr. Lal PathLabs had revenue of 7.98B INR in the quarter ending June 30, 2026, with 19.10% growth. This brings the company's revenue in the last twelve months to 28.91B, up 14.29% year-over-year. In the fiscal year ending March 31, 2026, Dr. Lal PathLabs had annual revenue of 27.63B with 12.25% growth.
Revenue (ttm)
28.91B
Revenue Growth
+14.29%
P/S Ratio
11.01
Revenue / Employee
5.55M
Employees
5,206
Market Cap
318.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 27.63B | 3.02B | 12.25% |
| Mar 31, 2025 | 24.61B | 2.35B | 10.54% |
| Mar 31, 2024 | 22.27B | 2.10B | 10.40% |
| Mar 31, 2023 | 20.17B | -705.26M | -3.38% |
| Mar 31, 2022 | 20.87B | 5.06B | 32.01% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 111.75B |
| Piramal Pharma | 92.05B |
| Emcure Pharmaceuticals | 92.04B |
| Global Health | 46.83B |
| Krishna Institute of Medical Sciences | 39.05B |
Dr. Lal PathLabs News
- 9 days ago - Dr. Lal PathLabs Transcript: Q1 26/27 - Transcripts
- 9 days ago - Dr. Lal PathLabs Quarterly report: Q1 2027 - Filings
- 9 days ago - Dr. Lal PathLabs Slides: Q1 2027 - Filings
- 9 days ago - India's Dr Lal PathLabs posts higher first-quarter profit on healthy demand for tests - Reuters
- 10 days ago - Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) Q1 2027 Earnings Report Preview: What to Expect - GuruFocus
- 3 months ago - Dr. Lal PathLabs Earnings Call Transcript: Q4 2026 - Transcripts
- 3 months ago - Dr. Lal PathLabs Quarterly report: Q4 2026 - Filings
- 3 months ago - Dr. Lal PathLabs Slides: Q4 2026 - Filings